The final report defined the tumor as a metastatic high-grade serous adenocarcinoma of unknown origin that was positive for CK7, ER, paired box gene 8 (PAX8) and p53 and negative for CK20, PR and CDX2 (Fig. 2). The gene discussed is CDX2; the disease is neoplasm.